Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Tenofovir'

Tenofovir published presentations and documents on DocSlides.

F.G.M.RusselTable2.1

F.G.M.RusselTable2.1

  • liane-varnes
  • 23 Slides

GeneProteinMechanismTissuedistributionlocalization...

State

State

  • pasty-toler
  • 49 Slides

of the evidence from oral and topical . PrEP. ef...

The Bangkok Tenofovir Study

The Bangkok Tenofovir Study

  • marina-yarberry
  • 41 Slides

An HIV pre-exposure prophylaxis trial in Thailand...

Tenofovir

Tenofovir

  • alida-meadow
  • 101 Slides

based . PrEP. technologies in women : . what do...

Managing Antiretroviral Failure in 2012

Managing Antiretroviral Failure in 2012

  • sherrill-nordquist
  • 18 Slides

Jennifer Hoy. , MBBS. Professor of Medicine. Dire...

HIV Medication Overview

HIV Medication Overview

  • kittie-lecroy
  • 63 Slides

John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. A...

EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)

EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)

  • tawny-fly
  • 20 Slides

M Harris, . S Guillemi. , K Chan, B Yip. ,. . M ...

W orking

W orking

  • min-jolicoeur
  • 16 Slides

with . Different Groups. Module 3 (f). People who...

Major Changes to the HHS Adult and Adolescent HIV Treatment

Major Changes to the HHS Adult and Adolescent HIV Treatment

  • tawny-fly
  • 14 Slides

Brian R. Wood, MD. Assistant Professor of Medicin...

New Prevention Technologies Workshop

New Prevention Technologies Workshop

  • olivia-moreira
  • 21 Slides

Module 5: . State of NPT Research. www.icad-cisd....

ID Week Review 2015

ID Week Review 2015

  • briana-ranney
  • 17 Slides

Brian R. Wood, MD. Assistant Professor of Medicin...

Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of

Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of

  • briana-ranney
  • 0 Slides

B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...

AHCCCS Pharmacy and Therapeutics Committee

AHCCCS Pharmacy and Therapeutics Committee

  • debby-jeon
  • 0 Slides

August 16, 2016. 5-17-16 Minutes. Review and vote...

Antiretroviral Updates:

Antiretroviral Updates:

  • tatyana-admore
  • 0 Slides

New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • liane-varnes
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

Conflict of Interest “No conflicts of interest to declare”

Conflict of Interest “No conflicts of interest to declare”

  • karlyn-bohler
  • 0 Slides

Lessons Learned from Tenofovir Vaginal Gel Studie...

Pre- and Post-Exposure Prophylaxis for HIV

Pre- and Post-Exposure Prophylaxis for HIV

  • stefany-barnette
  • 0 Slides

Kevin L. Ard, MD, MPH. October 20, 2016. Learning...

ART Initiation: PrEP and

ART Initiation: PrEP and

  • alida-meadow
  • 0 Slides

Treatment-naïve Patients . Clinical Instructor, ...

Pre-exposure Prophylaxis for HIV Prevention

Pre-exposure Prophylaxis for HIV Prevention

  • pamella-moone
  • 0 Slides

Efficacy and the importance of adherence. Joanne ...

Projecting the Impact of

Projecting the Impact of

  • marina-yarberry
  • 0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

Areas of Work Regulatory System Strengthening

Areas of Work Regulatory System Strengthening

  • marina-yarberry
  • 0 Slides

Access and Rational Use. Blood, Radiological and ...

Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi

Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi

  • conchita-marotz
  • 0 Slides

A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borka...

HIV Pharmacotherapy Focused Update

HIV Pharmacotherapy Focused Update

  • yoshiko-marsland
  • 0 Slides

Drew Lambert, . PharmD. lambertd@husson.edu. Huss...

2014: HIV, HCV, and HBV

2014: HIV, HCV, and HBV

  • kittie-lecroy
  • 0 Slides

Update. David Spach, MD. Professor of Medicine,...

HIV Pharmacotherapy Focused Update

HIV Pharmacotherapy Focused Update

  • sherrill-nordquist
  • 0 Slides

Drew Lambert, . PharmD. lambertd@husson.edu. Huss...

New Antiretrovirals for the Treatment

New Antiretrovirals for the Treatment

  • alida-meadow
  • 0 Slides

of HIV. . Convenience, tolerability, simplicity....

SHIV Infection and Drug Transporters Influence Brain Tissue Concentrations of Efavirenz

SHIV Infection and Drug Transporters Influence Brain Tissue Concentrations of Efavirenz

  • tatiana-dople
  • 0 Slides

Nithya Srinivas. 1. , John Fallon. 1. , Craig Syk...

Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, N

Prepared by the AETC National Coordinating Resource Center based on recommendations from the CDC, N

  • briana-ranney
  • 0 Slides

Guidelines for Prevention and Treatment of Opport...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • yoshiko-marsland
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • natalia-silvester
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

  • phoebe-click
  • 0 Slides

ACTIVITY CODE . TD342. Antiretroviral Medications...

HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional

HBV Clinical Management [TRAINER(S) NAME(S)] IAPAC African Regional

  • mitsue-stanley
  • 119 Slides

HBV Clinical Management [TRAINER(S) NAME(S)] IAPA...

TENOFOVIR ALAFENAMIDE PHARMACOKINETICS

TENOFOVIR ALAFENAMIDE PHARMACOKINETICS

  • studyne
  • 12 Slides

WITH AND WITHOUT COBICISTAT IN PREGNANCY . Jeremia...

Evolving Options for HBV Therapy:

Evolving Options for HBV Therapy:

  • desiron
  • 39 Slides

Navigating the New Treatment Landscape. Outline. I...

The goal of hepatitis C virus (HCV) treatment is a cure (when there is

The goal of hepatitis C virus (HCV) treatment is a cure (when there is

  • amey
  • 2 Slides

Genotype 1, never treated for HCV, no cirrhosis12 ...

IMPACT OF VAGINAL MICROBIOTA ON GENITAL TISSUE AND PLASMA CONCENTRATIONS OF DAPIVIRINE

IMPACT OF VAGINAL MICROBIOTA ON GENITAL TISSUE AND PLASMA CONCENTRATIONS OF DAPIVIRINE

  • sophie
  • 18 Slides

Sharon L Hillier, Leslie A Meyn, Katherine Bunge, ...

Tenofovir Alafenamide (TAF)

Tenofovir Alafenamide (TAF)

  • nicole
  • 18 Slides

in a Single-Tablet Regimen . in Initial HIV-1 Ther...

Renal and Bone Safety of

Renal and Bone Safety of

  • ashley
  • 16 Slides

Tenofovir. . Alafenamide. . vs. . Tenofovir. ....

Getting the FACTS Right!

Getting the FACTS Right!

  • sophie
  • 26 Slides

Update & Scenario Planning for FACTS001 Trial....

HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP

HIV Treatment 101 C. Ryan Tomlin, Pharm.D., BCPS, AAHIVP

  • Powerpixel
  • 42 Slides

Clinical Pharmacist – HIV Medicine. Outline. Wha...

Copyright © 2024 DocSlides. All Rights Reserved